Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2020-10-18
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Within the PHaRAo population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from PHaRAo patients. This cohort study is an open-end observational study to identify master switches in aortic disease
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
NCT05703893
Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms
NCT03142074
Male-female Differences in Immunohistological and Biomechanical Properties of the Thoracic Aorta
NCT05650892
Aortic Stiffness in Patients With Genetic Aortopathies
NCT05715203
4D Motion of the Aorta in the Chest and Simulated Wall Stress Distribution in Relation to Aortic Events
NCT04958083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy volunteers
Collection of Clinical Data
prospectively and systematically collection of clinical research data from apparently healthy volunteers and patients with aortic stenosis and aneurysms
patients with aortic stenosis
Collection of Clinical Data
prospectively and systematically collection of clinical research data from apparently healthy volunteers and patients with aortic stenosis and aneurysms
patients with aortic aneurysms
Collection of Clinical Data
prospectively and systematically collection of clinical research data from apparently healthy volunteers and patients with aortic stenosis and aneurysms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collection of Clinical Data
prospectively and systematically collection of clinical research data from apparently healthy volunteers and patients with aortic stenosis and aneurysms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
• Patients suffering from 3rd drgree Aortic Stenosis
• Patients suffering from Aortic Aneurysms
Exclusion Criteria
* Active Medication
* Cardiovascular Disease
* MRI not possible
2. Patients with Aortic Stenosis
* \< 18 years
* MRI not possible
3. Patients with Aortic Aneurysms
* \< 18 years
* MRI not possible
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heinrich-Heine University, Duesseldorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malte Kelm, MD
Role: STUDY_CHAIR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Christine Quast, MD
Role: PRINCIPAL_INVESTIGATOR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christine Quast
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Quast C, Bonner F, Polzin A, Veulemans V, Chennupati R, Gyamfi Poku I, Pfeiler S, Kramser N, Nankinova M, Staub N, Zweck E, Jokiel J, Keyser F, Hoffe J, Witkowski S, Becker K, Leuders P, Zako S, Erkens R, Jung C, Flogel U, Wang T, Neidlin M, Steinseifer U, Niepmann ST, Zimmer S, Gerdes N, Cortese-Krott MM, Feelisch M, Zeus T, Kelm M. Aortic Valve Stenosis Causes Accumulation of Extracellular Hemoglobin and Systemic Endothelial Dysfunction. Circulation. 2024 Sep 17;150(12):952-965. doi: 10.1161/CIRCULATIONAHA.123.064747. Epub 2024 Jun 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHaRAo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.